Editorial & Opinion
Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second?
| العنوان: | Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second? |
|---|---|
| المؤلفون: | Knightly KA; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA., Bussel JB; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA.; Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA., McKelvy M; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA.; Renaissance School of Medicine at Stony Brook University, New York, NY, USA., Vander Haar E; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA. |
| المصدر: | American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 468-472. Date of Electronic Publication: 2024 Jan 11. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York Ny : Wiley-Blackwell Original Publication: New York, Liss. |
| مواضيع طبية MeSH: | Thrombocytopenia, Neonatal Alloimmune*/diagnosis, Pregnancy ; Infant, Newborn ; Female ; Humans ; Intracranial Hemorrhages/etiology ; Fetus ; Immunoglobulins, Intravenous |
| References: | Bussel J, Berkowitz R, McFarland J, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. NEJM. 1988;319:1374-1378. doi:10.1056/NEJM198811243192103. Bussel JB, Berkowitz RL, Hung C, et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol. 2010;203(2):135.e1-135.e14. doi:10.1016/j.ajog.2010.03.011. Radder CM, Brand A, Kanhai HHH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang. 2003;84(4):318-325. doi:10.1046/j.1423-0410.2003.00302.x. Ernstsen SL, Ahlen MT, Johansen T, Bertelsen EL, Kjeldsen-Kragh J, Tiller H. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies. Am J Obstet Gynecol. 2022;227(3):506.e1-506.e12. doi:10.1016/j.ajog.2022.04.044. Mckelvy M, Tyagi S, Haar EV, et al. Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia? doi:10.22541/au.169411866.63459816/v1. de Vos TW, van Zagten M, de Haas M, et al. Children newly diagnosed with fetal and neonatal alloimmune thrombocytopenia: neurodevelopmental outcome at school age. J Pediatr. 2023;258:113385. doi:10.1016/j.jpeds.2023.02.031. |
| المشرفين على المادة: | 0 (Immunoglobulins, Intravenous) |
| تواريخ الأحداث: | Date Created: 20240111 Date Completed: 20240214 Latest Revision: 20240726 |
| رمز التحديث: | 20240727 |
| DOI: | 10.1002/ajh.27193 |
| PMID: | 38205912 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.27193 |